Contract development and manufacturing organizations (CDMOs) are constantly evolving, offering new services to customers to highlight their strengths and to differentiate themselves in the market place.
In this Drug Development & Delivery Special Feature, Dr Martin Koeberle (Head of Analytical Development and Stability Testing at HERMES PHARMA), along with other leading CDMOs, talks about HERMES PHARMA’S focus on ensuring quality right from the start of the manufacturing process using QbD. Read the article to learn:
Why companies are considering quality earlier in the pharmaceutical manufacturing process
How HERMES PHARMA applies QbD principles to cost-effectively manufacture pleasant-tasting orally disintegrating granules (ODGs) using hot melt coating
How HERMES PHARMA has established a quality system so that customers can outsource both their formulation development and clinical trial sponsorship